Edico Genome Signs Contracts With NHGRI And NCI For Use Of DRAGEN For Cancer Research
SAN DIEGO, Aug. 2, 2017 — Edico Genome today announced it has signed contracts with the National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI) for the use of its DRAGENTM(Dynamic Read Analysis for Genomics) Bio-IT platform. Continuing their initiatives to advance cancer research, NHGRI and NCI purchased Edico Genome’s DRAGEN Somatic pipeline and DRAGEN Genome pipeline, ensuring accuracy, reducing costs... Read more